FrontPage is India's Stock Market Social Network
Join 50,000+ Traders and Investors

MOREPENLAB

23.45
+0.15 (0.64%)
Updated 03:29 13/07 IST

MOREPENLAB Buy or Sell - FrontPage Forums

0 Users have submitted 0 trade ideas of Rs. 0 for MOREPENLAB
Disclaimer
0% Bullish
0% Bearish

MOREPENLAB Buy or Sell - Brokerage Reports

No. of reports in last year
0
No. of analysts
0
Average Consensus Forecast
Consensus Potential
0.00%
See MOREPENLAB Share Price Targets >>

MOREPENLAB Ratings

Long term MOREPENLAB rating by FrontPage users
0/5 (0 Ratings)0
Find answers to all your questions on live MOREPENLAB message board: Is MOREPENLAB buy or sell? Should I buy MOREPENLAB shares? Why are MOREPENLAB shares falling? Should I invest in MOREPENLAB stock?

  1. Home
  2. MOREPENLAB Forum

MOREPENLAB Share Price Discussion

N
Reputation: 3,531 • Jun 23 3:08 AM
Morepen Lab Standalone March 2020 Net Sales at Rs 189.15 crore, down 8.21% Y-o-Y
Moneycontrol
Like
Reply
N
Reputation: 3,531 • Jun 23 3:08 AM
Morepen Lab Consolidated March 2020 Net Sales at Rs 206.60 crore, down 5.54% Y-o-Y
Moneycontrol
Like
Reply
A
Reputation: 6,130 • Jun 23 2:16 AM

Profit at Rs 11.02 cr versus Rs 10.49 cr, revenue at Rs 206.60 cr versus Rs 218.71 cr YoY.
Like
Reply
N
Reputation: 3,531 • Jun 22 1:38 AM
Morepen Labs Q4 net profit rises 5% to Rs 11 crore
For the full financial year 2019-20, its net profit was Rs 33.57 crore. It was Rs 28.84 crore for the previous financial year, Morepen Labs said.
Moneycontrol
Like
Reply

Type
Buy
Instrument
MOREPENLAB
Entry Price
₹30
Price@Trade
₹30
Target Price
₹32
Stop Price
₹29.4
Valid Till
Jun 17, 2020 3:20 AM
Margin
₹60,000 approx for 2000 Qty
Status
Exited
Exit Price
₹30.1
Net P&L
+₹200 (+0.33%)
Like
Reply (1)
Latest replies
Mayur @mayur-B1xumduepU
Jun 17 4:45 AM

Update
Exited
Exit Price
₹30.1
Net P&L
+₹200 (+0.33%)

Type
Buy
Instrument
MOREPENLAB
Entry Price
₹27
Price@Trade
₹29.6
Target Price
₹65
Stop Price
₹25.8
Valid Till
Jun 17, 2021 3:20 AM
Margin
₹27,000 approx for 1000 Qty
Status
Exited before entry
Like
Reply (1)
Latest replies
Mayur @mayur-B1xumduepU
Jun 17 4:45 AM

Update
Exited before entry
Price @ Update
₹30.1

MOREPENLAB - 910532
Made high 26.60 (locked in upper circuit) up 30%~ in just 2 sessions
4
Reply
N
Reputation: 3,812 • Jun 16 4:08 AM

Type
Buy
Instrument
MOREPENLAB
Entry Price
₹26.6
Price@Trade
₹26.6
Target Price
₹30
Stop Price
₹24
Valid Till
Jul 16, 2020 3:20 AM
Margin
₹79,800 approx for 3000 Qty
Status
Target Achieved
Exit Price
₹30
Net P&L
+₹10,200 (+12.78%)
Like
Reply (1)
Latest replies
TrackerBot @trackerbot
Jun 17 2:48 AM

Update
Target Achieved
Exit Price
₹30

Type
Buy
Instrument
MOREPENLAB
Entry Price
₹22  ₹22.25
Price@Trade
₹22.3
Target Price
₹36
Stop Price
₹16.95
Valid Till
Jun 15, 2021 3:20 AM
Margin
₹22,250 approx for 1000 Qty
Status
Exited
Exit Price
₹22.35
Net P&L
+₹100 (+0.45%)
Like
Reply (4)
Latest replies
krishana Prajapati @krishana
Jun 15 5:46 AM

Update
Entry Price Modified
Price @ Update
₹22.2
Original Entry Price
₹22
New Entry Price
₹22.2
krishana Prajapati @krishana
Jun 15 5:47 AM

Update
Entry Price Modified
Price @ Update
₹22.25
Original Entry Price
₹22.2
New Entry Price
₹22.25
TrackerBot @trackerbot
Jun 15 5:47 AM

Update
Trade Entered
Entry Price
₹22.25
krishana Prajapati @krishana
Jun 15 7:59 AM

Update
Exited
Exit Price
₹22.35
Net P&L
+₹100 (+0.45%)
N
Reputation: 3,531 • Apr 30 4:13 AM
Morepen Labs share price jumps 5% after UK standards body certifies company's Himachal unit
The stock surged over 100 percent in the last 1 month. There were pending buy orders of 299 shares, with no sellers available.
Moneycontrol
Like
Reply
N
Reputation: 3,531 • Apr 21 3:43 AM
Morepen Labs shares surge 8% on license to manufacture Hydroxychloroquine
Morepen Laboratories has launched non-contact Infrared thermometers, alcohol-based hand sanitizers, hand wash, hand rubs and face masks.
Moneycontrol
Like
Reply

Jackpot stock
Buy morepenlab @16.50-17 sl 15.50 tgt 10-20-40% in 2-5 days
Good fundamantal & multibagger stock mid to long term tgt 50-100+++
1
Reply
N
Reputation: 3,531 • Sep 25, 2019 3:48 AM
Morepen Laboratories falls 17% after SEBI ban on accessing security market for a year
The company says there will be no impact of the order on the securities listed with the stock exchanges and on business operations.
Moneycontrol
Like
Reply
N
Reputation: 3,531 • Sep 25, 2019 1:38 AM
Stocks in the news: Kaveri Seed, RPP Infra, Aurobindo Pharma, Morepen Labs, Indiabulls Housing
Indiabulls Housing Finance | SBI | Kaveri Seed Company | Munjal Auto | RPP Infra | Rane Engine Valve | Bodal Chemicals and Aster DM Healthcare are among stocks which are in news today.
Moneycontrol
Like
Reply
N
Reputation: 3,531 • Sep 20, 2019 1:38 AM
Stocks in the news: Yes Bank, PNB, Bharat Forge, Reliance Power, Adani Transmission, JSW Steel
Yes Bank | Reliance Power | Lincoln Pharmaceuticals | Morepen Laboratories | and PNB are among stocks which are in news today.
Moneycontrol
Like
Reply
N
Reputation: 3,531 • Sep 20, 2019 1:18 AM
Stocks in the news: Yes Bank, DHFL, PNB, Bharat Forge, Reliance Power, Adani Transmission
Yes Bank | Reliance Power | Lincoln Pharmaceuticals | Morepen Laboratories | and PNB are among stocks which are in news today.
Moneycontrol
Like
Reply
N
Reputation: 3,531 • Sep 19, 2019 2:38 AM
Trade Setup for Friday: Top 15 things to know before Opening Bell
Key support level for Nifty is placed at 10,634.93, followed by 10,565.07. If the index starts moving up, key resistance levels to watch out for are 10,809.93 and 10,915.07.
Moneycontrol
Like
Reply
N
Reputation: 3,531 • Sep 17, 2019 1:53 AM
Stocks in the news: DLF, Aavas Financiers, TCS, NBCC, Kaveri Seed, Wipro, Mindtree, TRF
DLF, Aavas Financiers, TCS, NBCC, Wipro, Mindtree
Moneycontrol
Like
Reply
N
Reputation: 3,531 • Aug 13, 2019 11:13 AM
Morepen Lab Standalone June 2019 Net Sales at Rs 189.47 crore, up 25.61% Y-o-Y
moneycontrol.com
Like
Reply
Join FrontPage
FrontPage is India's favorite stock discussions community
Join 50,000 Indian traders and discuss trades, strategies, news & views on any stock.
  • MOREPENLAB - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization1,387.63
    Enterprise Value1,515.93
    Price to Earnings53.37
    Price to Book Value5.53
    Return on Capital Employed0.08
    Return on Equity0.1
    Face Value2
    Dividend YieldNA
  • MOREPENLAB Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Jul 1323.524.123.2523.4
    Jul 1023.524.1523.2523.3
    Jul 823.524.4523.0523.75
    Jul 723.724.3523.1523.3
    Jul 623.425.323.423.95
  • MOREPENLAB Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹25.7
    30 Day Moving Average₹23.51
    50 Day Moving Average₹20.7
    100 Day Moving Average₹16.75
    200 Day Moving Average₹16.46
  • MOREPENLAB - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue561537.040.04
    Operating Profit6059.90
    Profit Before Tax2623.040.13
    Net Income2623.040.13
  • MOREPENLAB - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds251351.9-0.29
    Total Liabilities340315.630.08
    Total Assets591547.880.08
  • MOREPENLAB - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity6164.55-0.05
    Cash from Investing Activity-24-14.510.65
    Cash from Financing Activity-38-46.92-0.19
    Net Cash Flow-13.11-1.32
  • MOREPENLAB - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.040.04
    Return on Equity0.10.07
    Return on Capital Employed0.080.08
  • MOREPENLAB - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue0.52
    3 Year CAGR Growth in Operating Profit0.29
    3 Year CAGR Growth in EBIDTA0.31
    3 Year CAGR Growth in Net Income43.83
    3 Yr CAGR Growth - Diluted EPS57
  • MOREPENLAB - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue0.85
    5 Year CAGR Growth in Operating Profit1.07
    5 Year CAGR Growth in EBIDTA0.82
    5 Year CAGR Growth in Net Income2.15
    3 Yr CAGR Growth - Diluted EPS2.16
  • MOREPENLAB - Recent News

    keyboard_arrow_down
    NewsBot
    Jun 23 3:08 AM
    Morepen Lab Standalone March 2020 Net Sales at Rs 189.15 crore, down 8.21% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 23 3:08 AM
    Morepen Lab Consolidated March 2020 Net Sales at Rs 206.60 crore, down 5.54% Y-o-Y
    Moneycontrol
    NewsBot
    Jun 22 1:38 AM
    Morepen Labs Q4 net profit rises 5% to Rs 11 crore
    Moneycontrol
    NewsBot
    Apr 30 4:13 AM
    Morepen Labs share price jumps 5% after UK standards body certifies company's Himachal unit
    Moneycontrol
    NewsBot
    Apr 21 3:43 AM
    Morepen Labs shares surge 8% on license to manufacture Hydroxychloroquine
    Moneycontrol
    NewsBot
    Sep 25, 2019 3:48 AM
    Morepen Laboratories falls 17% after SEBI ban on accessing security market for a year
    Moneycontrol
    NewsBot
    Sep 25, 2019 1:38 AM
    Stocks in the news: Kaveri Seed, RPP Infra, Aurobindo Pharma, Morepen Labs, Indiabulls Housing
    Moneycontrol
    NewsBot
    Sep 20, 2019 1:38 AM
    Stocks in the news: Yes Bank, PNB, Bharat Forge, Reliance Power, Adani Transmission, JSW Steel
    Moneycontrol
    NewsBot
    Sep 20, 2019 1:18 AM
    Stocks in the news: Yes Bank, DHFL, PNB, Bharat Forge, Reliance Power, Adani Transmission
    Moneycontrol
    NewsBot
    Sep 19, 2019 2:38 AM
    Trade Setup for Friday: Top 15 things to know before Opening Bell
    Moneycontrol
  • MOREPENLAB - Related Communities

    keyboard_arrow_down
    Sun Pharmaceutical Industries Ltd. NS...
    Aurobindo Pharma Ltd. NSE: AUROPHARMA...
    Cipla Ltd. NSE: CIPLA | BSE: 500087 |...
    Biocon Ltd. NSE: BIOCON | BSE: 532523...
    Lupin Ltd. NSE: LUPIN | BSE: 500257 |...
    Dr. Reddy's Laboratories Ltd. NSE: DR...
    Glenmark Pharmaceuticals Ltd. NSE: GL...
    Piramal Enterprises Ltd. NSE: PEL | B...
    Divi's Laboratories Ltd. NSE: DIVISLA...
    Apollo Hospitals Enterprise Ltd. NSE:...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and FrontPage will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein.

PrivacyTerms
FrontPage © 2020